Analyst Ratings for Biogen (BIIB)
BIIB Rating Summary
BIIB Price Target Summary
- Highest: $300.00 (Baird)
- Lowest: $89.00 (Stifel)
- Average: $190.38
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$190.38 (+60.5%)
* Over Last 12-Mos
Rating Score: 4.8 / 10
Percentile Rank: 48%
Rating Score: 4.8 / 10
Percentile Rank: 48%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/4/2025 | Argus | Jasper Hellweg | Downgrade | Hold (Buy) |
N/A (N/A) |
130.71 (118.61) |
-9.26% | Details |
| 2/11/2025 | Bernstein SocGen Group » Updated 2/18/2025 |
William Pickering | New Coverage | Market Perform (N/A) |
159.00 (160.00) |
141.35 (118.61) |
-16.09% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
